| Efficacy of combinations of colistin with other antimicrobials involves membrane fluidity and efflux machinery E Armengol, O Domenech, E Fusté, I Pérez-Guillén, JH Borrell, JM Sierra, ... Infection and Drug Resistance, 2031-2038, 2019 | 27 | 2019 |
| Current strategies to determine antifungal and antimicrobial activity of natural compounds E Sanchez Armengol, M Harmanci, F Laffleur Microbiological Research 252, 126867, 2021 | 24 | 2021 |
| Is hyaluronic acid the perfect excipient for the pharmaceutical need? D Harrer, E Sanchez Armengol, JD Friedl, A Jalil, M Jelkmann, C Leichner, ... International Journal of Pharmaceutics 601, 120589, 2021 | 24 | 2021 |
| When combined with colistin, an otherwise ineffective rifampicin–linezolid combination becomes active in Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii E Armengol, T Asunción, M Viñas, JM Sierra Microorganisms 8 (1), 86, 2020 | 17 | 2020 |
| PEGylated drug delivery systems in the pharmaceutical field: past, present and future perspective E Sanchez Armengol, A Unterweger, F Laffleur Drug Development and Industrial Pharmacy 48 (4), 129-139, 2022 | 13 | 2022 |
| The progress on sulfhydryl modified polymers with regard to synthesis, characterization and mucoadhesion E Sanchez Armengol, F Laffleur International Journal of Pharmaceutics 592, 120016, 2021 | 8 | 2021 |
| Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms E Armengol, KN Kragh, T Tolker-Nielsen, JM Sierra, D Higazy, O Ciofu, ... Antimicrobial Agents and Chemotherapy 67 (4), e01641-22, 2023 | 3 | 2023 |
| Allergies caused by textiles: control, research and future perspective in the medical field E Sanchez Armengol, AB Kerezsi, F Laffleur International Immunopharmacology 110, 109043, 2022 | 3 | 2022 |
| Generations of chitosan: The progress in drug delivery E Sanchez Armengol, F Laffleur Chitosan for Biomaterials IV, 191-212, 2021 | 3 | 2021 |
| Chitosan–maleic acid conjugate as potential excipient candidate for oral drug delivery? E Sanchez Armengol, P Knoll, A Hupfauf, R Gust, F Laffleur Future Medicinal Chemistry, 2023 | 1 | 2023 |
| Inhibition of P-glycoprotein-mediated efflux by thiolated cyclodextrins F Veider, S Haddadzadegan, ES Armengol, F Laffleur, G Kali, ... Carbohydrate Polymers 327, 121648, 2024 | | 2024 |
| Ocular antibacterial chitosan-maleic acid hydrogels: In vitro and in vivo studies for a promising approach with enhanced mucoadhesion ES Armengol, B Grassiri, AM Piras, Y Zambito, A Fabiano, F Laffleur International Journal of Biological Macromolecules 254, 127939, 2024 | | 2024 |
| Design of biodegradable nanoparticles for enzyme-controlled long-acting drug release N Hock, D To, ES Armengol, S Summonte, A Seybold, C Federer, ... Journal of Drug Delivery Science and Technology 89, 105085, 2023 | | 2023 |
| P139 Colistin-rifampicin combination is efficient against biofilms of colistin-resistant Pseudomonas aeruginosa from cystic fibrosis patients O Ciofu, E Armengol, KN Kragh, T Tolker-Nielsen, M Viñas, N Høiby Journal of Cystic Fibrosis 21, S103-S104, 2022 | | 2022 |
| Screening of channel-forming toxins from Bacillus isolates obtained from tobacco E Fusté, A Merlos, E Armengol, D Rodrigo, G Briceño, M Winterhalter, ... Avances en microbiología, 145-146, 2015 | | 2015 |
| Design of Biodegradable Nanoparticles for Enzyme-Controlled Ultra-Long-Acting Drug Release N Hock, D To, ES Armengol, S Summonte, A Seybold, C Federer, ... Available at SSRN 4555718, 0 | | |
